Novartis India Limited

As of March 31, 2026, Novartis India Limited carries a market capitalization of 23.97B, placing it among publicly traded companies globally. Its enterprise value stands at 17.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Novartis India Limited has 24.69M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Novartis India Limited maintains a current ratio of 5.30, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Novartis India Limited recorded 280.50M in income tax expense.

As of the close on October 22, 2026, Novartis India Limited's stock has gained approximately 93.25% over the past 52 weeks. The 50-day moving average sits at 1,822.99, while the 200-day moving average is 1,309.83.

As of March 31, 2026, Novartis India Limited holds 6.58B in cash and equivalents against 32.10M in total debt, resulting in a net debt position of -525.00M. Total book value stands at 8.18B, with working capital of 6.23B providing operational flexibility.

Novartis India Limited's most recent stock split took place on December 30, 1997 with a 1:10 split ratio.